Use access key #2 to skip to page content.

IBDvalueinvestin (99.66)

How oversold is XNPT? Well is MITI worth $300M more than XNPT?

Recs

5

February 18, 2010 – Comments (3) | RELATED TICKERS: XNPT , CTIC , MITI.DL

or for that matter is CYTX worth $100M more than XNPT or CTIC worth $190M more than XNPT.

Putting things in perspective shows how oversold XNPT currently is trading at $6.58/shr with mkt cap around $198M

 XNPT has more cash and further potential than the majority of these biotechs with higher market caps currently:

 

Biotech company, symbol, mkt cap size as of 2/18/10

ViroPharma Inc. (VPHM)    791.5M   
InterMune Inc. (ITMN)733.2M   
Alnylam Pharmaceuticals, Inc. (ALNY)    731.4M   
Exelixis, Inc. (EXEL)719.5M   
Momenta Pharmaceuticals Inc. (MNTA)693.5M
VIVUS Inc. (VVUS)690.3M
Martek Biosciences Corp. (MATK)    688.7M   
Theravance Inc. (THRX)    661.7M   
Xenoport, Inc. (XNPT)    594.7M
Micromet, Inc. (MITI)    551.9M   
Targacept, Inc. (TRGT)    551.5M   
Halozyme Therapeutics, Inc. (HALO)528.8M   
Cadence Pharmaceuticals Inc. (CADX)482.8M   
Emergent BioSolutions, Inc. (EBS)459.2M   
Eurand N.V. (EURX)456.2M   
Clinical Data, Inc. (CLDA)451.2M   
Enzon Pharmaceuticals Inc. (ENZN)425.9M   
Facet Biotech Corporation (FACT)422.1M   
ZymoGenetics, Inc. (ZGEN)411.5M   
Immunogen Inc. (IMGN)401.5M   
Affymax, Inc. (AFFY)400.4M   
Cell Therapeutics, Inc. (CTIC)396.4M   
Optimer Pharmaceuticals, Inc. (OPTR)393.0M   
American Oriental Bioengineeri (AOB)340.7M   
Sequenom Inc. (SQNM)327.1M   
Jazz Pharmaceuticals, Inc. (JAZZ)323.9M   
Lexicon Pharmaceuticals, Inc. (LXRX)    323.3M   
Vanda Pharmaceuticals, Inc. (VNDA)296.5M   
Cytori Therapeutics, Inc. (CYTX)294.1M
Sinovac Biotech Ltd. (SVA)289.6M   
Osiris Therapeutics, Inc. (OSIR)    288.4M   
BioCryst Pharmaceuticals, Inc. (BCRX)    278.0M   
Questcor Pharmaceuticals, Inc. (QCOR)    277.8M   
Ariad Pharmaceuticals Inc. (ARIA) 274.6M
3SBio Inc. (SSRX) 266.4M
Nabi Biopharmaceuticals (NABI)    265.5M
GenVec Inc. (GNVC)259.5M
QLT Inc. (QLTI)257.3M   
Dyax Corp. (DYAX) 255M
Omni Bio Pharmaceutical, Inc. (OMBP.OB)    254.6M
Obagi Medical Products, Inc. (OMPI) 241.5M   
Sangamo Biosciences Inc. (SGMO)    233.5M
Novavax, Inc. (NVAX)    227.2M
Cypress Bioscience, Inc. (CYPB)    203.7M
Idenix Pharmaceuticals Inc. (IDIX) 201.7M    

3 Comments – Post Your Own

#1) On February 18, 2010 at 11:08 PM, JPG101 (< 20) wrote:

I obviously agree there is a lot of seemingly arbitrary valuation in biotech. That's how and why there might be so much money to be made with this!

I certainly agree that CTIC isn't worth 180 million more then anything but strongly believe Micromet and Sinovac (to use 2 examples from your list) are worth very significantly more then XNPT. Very very significantly more. That's why I own them and not XNPT. For a believer in XNPT this could be a golden buying opportunity but then again restless leg syndrome, like insomnia, are difficult and dangerous labels as XNPT just found out!

 

JPG

Report this comment
#2) On February 18, 2010 at 11:10 PM, JPG101 (< 20) wrote:

I obviously agree there is a lot of seemingly arbitrary valuation in biotech. That's how and why there might be so much money to be made with this!

I certainly agree that CTIC isn't worth 180 million more then anything but strongly believe Micromet and Sinovac (to use 2 examples from your list) are worth very significantly more then XNPT. Very very significantly more. That's why I own them and not XNPT. For a believer in XNPT this could be a golden buying opportunity but then again restless leg syndrome, like insomnia, are difficult and dangerous labels as XNPT just found out!

 

JPG

Report this comment
#3) On February 19, 2010 at 7:54 AM, hansjang (< 20) wrote:

I strongly agree with you.

 

Report this comment

Featured Broker Partners


Advertisement